StockData
Phibro Animal Health Corp logo

Phibro Animal Health Corp (PAHC) stock

PAHCNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 22/3046% below fair value
$34.92−0.10 (-0.29%)

Close on Nov 17, 2026Market cap $1.42BP/E 14.4Yield 1.37%

Phibro Animal Health price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Phibro Animal Health's price to sales ratio was 0.9× on Nov 11, 2026, against 1.2× a year earlier. Over the last 5 years it ranged from 0.4× to 1.5×, with a median of 0.8×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.9×−0.1
2025Dec 31, 20251.1×+0.3
2024Dec 31, 20240.8×+0.3
2023Dec 29, 20230.5×−0.1
2022Dec 30, 20220.6×−0.4
2021Dec 31, 20211.0×−0.0
2020Dec 31, 20201.0×+0.1
2019Dec 31, 20190.9×+0.5
2018Dec 31, 20180.4×−0.0
2017Dec 29, 20170.4×−0.1
2016Jul 29, 20160.6×−0.7
2015Dec 31, 20151.2×−0.3
2014Dec 31, 20141.5×–

More Phibro Animal Health figures

See a number that looks wrong?